Glycans in Diseases and Therapeutics

Glycomedicine functions as essential role in cell-cell adhesion i.e. a device used by cells of the immune system through sugar-binding proteins called lectins, which classify precise carbohydrate portions. Glycans (carbohydrate oligomers) are the so-called “building blocks” of carbohydrates, nucleic acids, proteins and lipids play leading roles in various biological phenomena as well as in numerous pathophysiological procedures. Several scientists have now understood that glycosylation, i.e. the count of glycans to a protein backbone, is the most plentiful post translational alteration responses and is a major field of research and sometimes they require a glycobiology method to be exploited

  • Glycoprofiling
  • Glycomedicine
  • Transfusion medicine
  • Cancer biomarkers
  • Cardiovascular diseases
  • Computational and theoretical Biophysics

Related Conference of Glycans in Diseases and Therapeutics

March 15-16, 2021

12th Tissue Repair and Regeneration Congress

Dubai, UAE
March 28-29, 2021

11th Glycobiology World Congress

Vienna, Austria
April 19-19, 2021

2nd International Conference on Nucleic Acids

London, UK
June 11-12, 2021

25th Global Congress on Biotechnology

Berlin, Germany
September 13-14, 2021

17th World Congress on Structural Biology

Prague, Czech Republic
September 27-28, 2021

25th European Biotechnology Congress

Dublin, Ireland

Glycans in Diseases and Therapeutics Conference Speakers

Recommended Sessions

Related Journals

Are you interested in